Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211666 · ClinicalTrials.gov registry record · NA
Improving Hypertension Control in East and Central Harlem
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 480
- Enrollment target
NCT00211666 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 480 participants.
The verdict
NCT00211666, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
Study Summary
This hypertension project is evaluating strategies developed to target problems underlying lack of blood pressure control among treated but uncontrolled hypertensive patients in East and Central Harlem.
Interventions
- BEHAVIORAL Nurse management, home blood pressure monitors, and a chronic disease self management course.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2002-09 |
| Est. Completion | 2006-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00211666
The ClinicalTrials.gov registry entry for NCT00211666 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nurse management, home blood pressure monitors, and a chronic disease self management course. is the first listed.
NCT00211666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00211666 about?
NCT00211666 is a clinical study titled "Improving Hypertension Control in East and Central Harlem". This hypertension project is evaluating strategies developed to target problems underlying lack of blood pressure control among treated but uncontrolled hypertensive patients in East and Central Harlem.
What is the current status of trial NCT00211666?
This trial is currently completed. It is a NA study. The enrollment target is 480 participants. The study started on 2002-09. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00211666?
The interventions under investigation include: Nurse management, home blood pressure monitors, and a chronic disease self management course. (BEHAVIORAL).
Who is sponsoring clinical trial NCT00211666?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.